The clinical development group is a highly skilled, scientifically and medically driven team, having the main responsibility to create new medicines with clear therapeutic benefit for patients.
The team works in close collaboration with our applied research group and in full knowledge of current and anticipated future market needs.
The group aims to achieve superior performance through:

• Innovative and strategic clinical drug development to differentiate from current available treatments and known activities of competitors
• Effective safety risk management
  
• Operational excellence with focus on quality, time and cost, and thereby maximizing our internal and external (CRO) resources
• Proactive and strategic interaction with regulatory authorities

This will continuously deliver value to NovImmune, keep the interest of our investors high and make NovImmune a premier partner.